§
Cui Bono
Bills Search Find My Rep Legislators Who Benefits Countries Methodology

HR3807-118

Introduced

To amend the Federal Food, Drug, and Cosmetic Act with respect to device shortage notifications.

118th Congress Introduced Jun 5, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To amend the Federal Food, Drug, and Cosmetic Act with respect to device shortage notifications., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture, Trade.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H543119D8E3444681B419085BCB6338C6: 1. Short title This Act may be cited as the Medical Device Shortage Reduction Act of 2023.
  • Section HC0FBBE24BB72490B8AD885624CCBFF00: 2. Clarifying device shortage notifications Section 506J(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356j(a)) is amended— in paragraph (2), by...
  • Section H4661D428E9CA4241BAD089F9A07C0BF7: 3. Supply chain risk management Section 506J of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356j) is amended by striking subsection (h) and inserting...
  • Section HEA2007CE02824AE7843A3A62B12CF7CB: 4. Clarifying voluntary notifications Section 506J(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356j(i)) is amended by adding at the end the...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To amend the Federal Food, Drug, and Cosmetic Act with respect to device shortage notifications., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Agriculture, Trade

Primary Purpose

This bill, To amend the Federal Food, Drug, and Cosmetic Act with respect to device shortage notifications., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Agriculture Trade

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients:
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies:
health care providers and patients:

Sponsors

Kathy Castor

Kathy Castor

D-FL | Primary Sponsor

Legislative Progress

Introduced
Introduced Committee Passed
Jun 5, 2023

Ms. Castor of Florida introduced the following bill; which was …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Agriculture Trade
Actor Mappings
"the_secretary"
→ The Secretary identified in the operative section

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology